Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate |
2003-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faeefb7ae29bf5a5316787a36dfbb13e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7121ea0839432991f25dd41ad1897974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2686bc7de4ff2efef71e7ea0795d4aa6 |
publicationDate |
2005-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005250748-A1 |
titleOfInvention |
Combination therapy of angiotensin converting enzyme inhibitor and eplerenone for treatment of cardiovascular disease |
abstract |
Combinations of an ACE inhibitor and an epoxy-steroidal aldosterone receptor antagonist are described for use in treatment of circulatory disorders. Of particular interest are therapies using epoxy-steroidal-type aldosterone receptor antagonist compounds, such as eplerenone, in combination with an angiotensin converting enzyme inhibitor. This co-therapy would be particularly useful to treat congestive heart failure while avoiding or reducing aldosterone-antagonist-induced side effects such as hyperkalemia. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010318371-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005239759-A1 |
priorityDate |
1999-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |